Loyola University Medical Center psychiatrist Angelos Halaris, MD, PhD, proposes a new treatment discipline called Psychocardiology” be used to treat patients diagnosed with depression and heart disease based on a study he led with the support of Loyola colleagues. Medical News Today reports that the “…inflammatory biomarker, interleukin-6, was significantly higher in the blood of 48 patients diagnosed with major depression than it was in 20 healthy controls.”
Harlais says that “Forty to 60 percent of heart disease patients suffer clinical depression and 30 to 50 percent of patients who suffer clinical depression are at risk of developing cardiovascular disease.”
Harlais believes stress is the key to understanding these factors of the heart and depression. How this will affect those who suffer other conditions in addition to heart disease and depression remains to be seen.
(Article adapted by Medical News Today from original press release.)
Powered by Facebook Comments